Literature DB >> 18417708

Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance.

Tristan Bolmont1, Florent Haiss, Daniel Eicke, Rebecca Radde, Chester A Mathis, William E Klunk, Shinichi Kohsaka, Mathias Jucker, Michael E Calhoun.   

Abstract

Microglial cells aggregate around amyloid plaques in Alzheimer's disease, but, despite their therapeutic potential, various aspects of their reactive kinetics and role in plaque pathogenesis remain hypothetical. Through use of in vivo imaging and quantitative morphological measures in transgenic mice, we demonstrate that local resident microglia rapidly react to plaque formation by extending processes and subsequently migrating toward plaques, in which individual transformed microglia somata remain spatially stable for weeks. The number of plaque-associated microglia increased at a rate of almost three per plaque per month, independent of plaque volume. Larger plaques were surrounded by larger microglia, and a subset of plaques changed in size over time, with an increase or decrease related to the volume of associated microglia. Far from adopting a more static role, plaque-associated microglia retained rapid process and membrane movement at the plaque/glia interface. Microglia internalized systemically injected amyloid-binding dye at a much higher rate in the vicinity of plaques. These results indicate a role for microglia in plaque maintenance and provide a model with multiple targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417708      PMCID: PMC3844768          DOI: 10.1523/JNEUROSCI.4814-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  Cerebral hemorrhage after passive anti-Abeta immunotherapy.

Authors:  M Pfeifer; S Boncristiano; L Bondolfi; A Stalder; T Deller; M Staufenbiel; P M Mathews; M Jucker
Journal:  Science       Date:  2002-11-15       Impact factor: 47.728

Review 2.  Immunotherapeutic approaches to Alzheimer's disease.

Authors:  Alon Monsonego; Howard L Weiner
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  ATP mediates rapid microglial response to local brain injury in vivo.

Authors:  Dimitrios Davalos; Jaime Grutzendler; Guang Yang; Jiyun V Kim; Yi Zuo; Steffen Jung; Dan R Littman; Michael L Dustin; Wen-Biao Gan
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

4.  Expression of APP in transgenic mice: a comparison of neuron-specific promoters.

Authors:  K Andrä; D Abramowski; M Duke; A Probst; K H Wiederhold; K Bürki; M Goedert; B Sommer; M Staufenbiel
Journal:  Neurobiol Aging       Date:  1996 Mar-Apr       Impact factor: 4.673

Review 5.  Alzheimer's disease: what multiphoton microscopy teaches us.

Authors:  Brian J Bacskai; Bradley T Hyman
Journal:  Neuroscientist       Date:  2002-10       Impact factor: 7.519

6.  Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice.

Authors:  Anna K Stalder; Florian Ermini; Luca Bondolfi; Werner Krenger; Guido J Burbach; Thomas Deller; Janaky Coomaraswamy; Matthias Staufenbiel; Regine Landmann; Mathias Jucker
Journal:  J Neurosci       Date:  2005-11-30       Impact factor: 6.167

7.  Visualization of microglia in living tissues using Iba1-EGFP transgenic mice.

Authors:  T Hirasawa; K Ohsawa; Y Imai; Y Ondo; C Akazawa; S Uchino; S Kohsaka
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

8.  Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

Authors:  Donna M Wilcock; Amyn Rojiani; Arnon Rosenthal; Gil Levkowitz; Sangeetha Subbarao; Jennifer Alamed; David Wilson; Nedda Wilson; Melissa J Freeman; Marcia N Gordon; Dave Morgan
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.

Authors:  Joanna L Jankowsky; Hilda H Slunt; Victoria Gonzales; Alena V Savonenko; Jason C Wen; Nancy A Jenkins; Neal G Copeland; Linda H Younkin; Henry A Lester; Steven G Younkin; David R Borchelt
Journal:  PLoS Med       Date:  2005-11-15       Impact factor: 11.069

View more
  186 in total

1.  Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Gaëlle Naert; Serge Rivest
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

2.  Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.

Authors:  Géraldine Poisnel; Anne-Sophie Hérard; Nadine El Tannir El Tayara; Emmanuel Bourrin; Andreas Volk; Frank Kober; Benoit Delatour; Thierry Delzescaux; Thomas Debeir; Thomas Rooney; Jésus Benavides; Philippe Hantraye; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2011-11-12       Impact factor: 4.673

3.  Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.

Authors:  Michael T Heneka; Fabian Nadrigny; Tommy Regen; Ana Martinez-Hernandez; Lucia Dumitrescu-Ozimek; Dick Terwel; Daniel Jardanhazi-Kurutz; Jochen Walter; Frank Kirchhoff; Uwe-Karsten Hanisch; Markus P Kummer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

4.  Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function.

Authors:  Emalick G Njie; Ellen Boelen; Frank R Stassen; Harry W M Steinbusch; David R Borchelt; Wolfgang J Streit
Journal:  Neurobiol Aging       Date:  2010-07-02       Impact factor: 4.673

5.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Authors:  Sungho Lee; Nicholas H Varvel; Megan E Konerth; Guixiang Xu; Astrid E Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

Review 6.  Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

Authors:  Elizabeth E Spangenberg; Kim N Green
Journal:  Brain Behav Immun       Date:  2016-07-06       Impact factor: 7.217

7.  Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice.

Authors:  Andrew W Kraft; Xiaoyan Hu; Hyejin Yoon; Ping Yan; Qingli Xiao; Yan Wang; So Chon Gil; Jennifer Brown; Ulrika Wilhelmsson; Jessica L Restivo; John R Cirrito; David M Holtzman; Jungsu Kim; Milos Pekny; Jin-Moo Lee
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Longitudinal in vivo two-photon fluorescence imaging.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  J Comp Neurol       Date:  2014-06-01       Impact factor: 3.215

10.  NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

Authors:  Nicholas H Varvel; Kiran Bhaskar; Maria Z Kounnas; Steven L Wagner; Yan Yang; Bruce T Lamb; Karl Herrup
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.